Fractyl Health receives IDE approval for Revita trial
The trial will assess Revita’s efficacy in maintaining weight loss following the discontinuation of its GLP-1 receptor agonist (GLP-1RA) drug therapy.
02 April 2024
02 April 2024
The trial will assess Revita’s efficacy in maintaining weight loss following the discontinuation of its GLP-1 receptor agonist (GLP-1RA) drug therapy.
Haemonetics anticipates Attune Medical to contribute between $30m and $35m in revenue by fiscal year 2025.
The iDREAM system uses AI and ECG technology for accurate, home-based detection of obstructive sleep apnoea syndrome.
The CarePath at-home digital diagnostic platform is designed for remote urologic care.
Ambu has been granted a patent for an electronic device that automatically manages participant compliance during video communication sessions.
The RENASYS NPWT system is designed to improve home-based care for patients with chronic wounds.
The diagnostic tool is designed to detect four rare genetic disorders in newborns.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.